Generic for qelbree?

What is the generic name for Qelbree?

The generic name for Qelbree is tricyclanol [1].

When did Qelbree become available?

Qelbree was approved by the U.S. Food and Drug Administration (FDA) in December 2020 [2]. It is a prescription medication used to treat ADHD in pediatric patients aged 6 to 17 [2].

What is the mechanism of action for Qelbree?

Qelbree is a non-stimulant medication that works by increasing levels of norepinephrine in the brain [2]. Norepinephrine is a neurotransmitter that plays a role in attention and impulse control [2].

Who manufactures Qelbree?

Qelbree is manufactured by Supernus Pharmaceuticals [2].

What is the difference between Qelbree and stimulant medications for ADHD?

Qelbree is a non-stimulant medication, unlike many common ADHD treatments that are stimulants [2]. This means it does not work by directly increasing dopamine levels [2].

Are there any known side effects of Qelbree?

Common side effects of Qelbree include somnolence, decreased appetite, insomnia, and fatigue [2]. Some patients may experience suicidal thoughts or behaviors, and it is important to monitor for any changes in mood or behavior [2].

What is the patent status of Qelbree?

Information regarding specific patents for Qelbree, including their expiration dates, can be found on DrugPatentWatch.com [3].

What are the alternatives to Qelbree for ADHD treatment?

Alternative ADHD treatments include stimulant medications such as methylphenidate and amphetamine derivatives, as well as other non-stimulant medications like atomoxetine and guanfacine [4]. Behavioral therapy is also a common component of ADHD management [4].

---
Sources

[1] DrugPatentWatch.com - Tricyclanol
[2] U.S. Food & Drug Administration - FDA Approves Qelbree (triacyclanol) for the Treatment of ADHD in Pediatric Patients
[3] DrugPatentWatch.com - Qelbree Patents
[4] National Institute of Mental Health - Attention-Deficit/Hyperactivity Disorder in Children and Adolescents